Updates matching "Access to Biomarker Testing"

The American Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now complete, the bill now awaits the signature of Governor Jared Polis. If enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing.

Earlier today, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the Pennsylvania State Capitol as a part of their annual Cancer Action Day advocating for several legislative proposals that aim to address the needs of patients across the cancer continuum. The American Cancer Society Cancer Action Network (ACS CAN) gives people impacted by cancer a powerful voice with lawmakers by holding an annual Cancer Action Day.

Cancer Advocates and Cyclists Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer

Advocates with the American Cancer Society Cancer Action Network (ACS CAN) commend the Hawaii State Legislature for the passage of HCR 53 during the 2024 legislative session. The resolution moves Hawaii one step closer to advancing legislation to expand access to the testing needed to connect cancer patients and those battling other diseases to precision treatments through biomarker testing.

DES MOINES, Iowa – Iowa Governor Kim Reynolds signed a bill today, expanding access to  biomarker testing to more patients statewide. The American Cancer Society Cancer Action Network (ACS CAN) and its team of volunteers, including cancer survivors, patients and caregivers, applaud the governor and

RALEIGH, N.C. – Around 50 cancer advocates, survivors, caregivers and their families from all over North Carolina will gather in Raleigh on Wednesday, May 1, to meet with lawmakers to ask them to support policies that reduce the burden of cancer in the Tar Heel State. The best time

Last week, legislation that seeks to improve New Jerseyans’ access to biomarker testing was introduced in the Legislature. Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. In some cases, biomarker testing may provide information that enables patients to forgo ineffective treatments and eliminate the potentially harmful, life-altering side effects of those treatments, which could also result in reduced health care costs.

DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure  biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.

The American Cancer Society Cancer Action Network is Encouraged as Flawed Biomarker Legislation Does Not Pass